PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer

PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer

Biliary tract cancer (BTC) represents the second most frequently diagnosed primary liver cancer worldwide following hepatocellular carcinoma, and the overall survival of patients with unresectable disease remains poor. In recent years, the advent of immune checkpoint inhibitors (ICIs) has revolution...

Full description

Bibliographic Details
Main Authors: Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
predictive biomarkers
PD-L1
TMB
immunotherapy
immune checkpoint inhibitors
biliary tract cancer
Online Access:https://www.mdpi.com/2072-6694/13/3/558

Similar Items

Similar Items